Surgery of Limited Clinical Benefit for Subacromial Shoulder Pain

This article originally appeared here.
Share this content:
Surgery of Limited Clinical Benefit for Subacromial Shoulder Pain
Surgery of Limited Clinical Benefit for Subacromial Shoulder Pain

TUESDAY, Nov. 21, 2017 (HealthDay News) -- For patients with subacromial shoulder pain, outcomes are better with arthroscopic subacromial decompression and investigational arthroscopy only, although the difference versus no treatment is not clinically important, according to a study published online Nov. 20 in The Lancet.

David J. Beard, D.Phil., from the University of Oxford in the United Kingdom, and colleagues randomized 313 patients with subacromial pain for at least three months with intact rotator cuff tendons in a 1:1:1 ratio to arthroscopic subacromial decompression, investigational arthroscopy only (placebo), or no treatment. Patients were followed up at six months and one year after randomization.

The researchers observed no significant difference in the mean Oxford Shoulder Score between the two surgical groups at six months (32.7 points with decompression versus 34.2 points with arthroscopy; mean difference, −1.3 points [95 percent confidence interval, −3.9 to 1.3; P = 0.3141]). A small benefit was seen for both surgical groups over no treatment (mean 29.4 points; mean difference versus decompression, 2.8 points [95 percent confidence interval, 0.5 to 5.2; P = 0.0186]; mean difference versus arthroscopy, 4.2 points [95 percent confidence interval, 1.8 to 6.6; P = 0.0014]); these differences were not clinically important. Six study-related complications occurred, all of which were frozen shoulders.

"The findings question the value of this operation for these indications, and this should be communicated to patients during the shared treatment decision-making process," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »